Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 94 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
931 12.1 months Malignant Pleural Mesothelioma 5 Alternative
Chemotherapy
University of Chicago, Cancer Research Center United States 7/2003
Treatment Details: Patients: This Phase III study involved a total of 448 patients with malignant pleural mesothelioma. Patients were divided into two groups. Group A was comprised of 226 patients and Group
 
932 12.0 months Malignant Pleural Mesothelioma 3 Radiation
Surgery
The University of Texas M. D. Anderson Cancer Center United States 3/2003
Treatment Details: Patients: This study involved seven patients with malignant pleural mesothelioma. Treatment: The treatment consisted of surgery followed by radiation. The surgery, extrapleural pneumonec
 
933 12.0 months Advanced colorectal cancer 5 Chemotherapy
Hospital Barmherzige Schwestern vom heiligen Kreuz Austria 7/2004
Treatment Details: Patients: This Phase I/II study involved 63 patients with advanced colorectal cancer. Treatment: Treatment consisted of three drugs irinotecan (camptosar), folinic acid (leucovorin),
 
934 12.0 months Advanced colorectal cancer 5 Chemotherapy
Hospital Barmherzige Schwestern vom heiligen Kreuz Austria 7/2004
Treatment Details: Patients: This Phase I/II study involved 63 patients with advanced colorectal cancer. Treatment: Treatment consisted of three drugs irinotecan (camptosar), folinic acid (leucovorin),
 
935 12.0 months Newly diagnosed GBM 5 Gene Therapy
Radiation
Surgery
Martin-Luther Universitat, Halle-Wittenberg Germany 11/2000
Treatment Details: Patients: This Phase III trial involved 248 patients with newly diagnosed, previously untreated glioblastoma multiforme. Patients were divided into two groups gene therapy group (124 patie
 
936 12.0 months Newly diagnosed GBM 4 Chemotherapy
Radiation
University of Tubingen Medical School Germany 1/2002
Treatment Details: Patients: This Phase II trial involved seventeen patients with newly diagnosed glioblastoma. Treatment: Treatment consisted of two chemotherapy drugs - gemcitabine (gemzar) and treosulfan
 
937 12.0 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Centre Jean Perrin France 4/2003
Treatment Details: Patients: A total of 114 glioma patients were given this regimen: 78 had gliobalstoma multiforme, 24 had anaplastic astrocytomas, and 12 had oligodendrogliomas. The patients had not received
 
938 12.0 months metastatic melanoma 3 Chemotherapy
University of Texas MD Anderson Cancer Center United States 10/2005
Treatment Details: Patients: This Phase II study involved 20 patients with metastatic melanoma, 13 men and 7 women. Treatment: The treatment consisted of a form of chemotherapy, arsenic trioxide. Toxicit
 
939 12.0 months Recurrent Ovarian cancer 4 Chemotherapy
University of Washington School of Medicine United States 6/2003
Treatment Details: Patients: This phase I/II study involved a total of 49 women with recurrent platinum resistant ovarian or peritoneal cancer. Treatment: The treatment consisted of two chemotherapy drugs
 
940 12.0 months GBM 4 Biologic therapy
Chemotherapy
Radiation
Sarah Cannon Research Institute United States 8/2010
Treatment Details: Patients: This study involved 47 patients with glioblastoma multiforme. The median age was 54 years (range of 28-79) and 66% were male. Treatment: Patients in this study received radio
 
Page 94 of 187  | Previous Page  | Next Page